Analyst Moves: EW, PEG

Posted on October 22, 2012 at 15:26 PM EDT

Edwards Lifesciences (EW) was downgraded by Citigroup (C) from buy to neutral with a price target of $95, as issues in the EU are likely to linger in the near term and affect earnings. Shares are lower by about one percent.

Related Stocks:

Citigroup, Inc. Credit Suisse Group ADS Edwards Lifesciences Corp. Public Service Enterprise Group, Inc.

Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates